ConductScience.org, home

Gene · 3860

NIH grants1,594

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleKRT13 papersNewest fiscal year
R01AI109023Defining P. falciparum resistance to artemisinin-based combination therapies352025
R01AI124678Elucidating the molecular basis of piperaquine resistance in Plasmodium falciparum162025
R37AI050234Defining the Role of PfCRT and PfMDR1 as Pleiotropic Mediators of Plasmodium falciparum Multidrug Resistance152025
R01AI117017Chemogenomic Profiling of Plasmodium Falciparum Responses and Resistance122025
P30DK050306Center for Molecular Studies in Digestive and Liver Diseases112025
P30DK078392Digestive Health Center (DHC): Bench to Bedside Research in Pediatric Digestive Disease82025
R01DC004336Engineering the Vocal Fold Mucosa82025
P30CA008748Cancer Center Support Grant72025
R01EY021797Development of Stem Cell-based Therapies for Limbal Stem Cell Deficiency72025
K24AI134990Mentoring in Translational Malaria Genomics62025
P30CA013696Cancer Center Support Grant62025
ZIAAI000892Malaria Parasite Genomics, Development, Drug Resistance, Pathogenesis, and Host-parasite Interaction62025
P30CA014089University of Southern California Norris Comprehensive Cancer Center Support Grant (CCSG)52025
P30CA016520Abramson Cancer Center Support Grant52025
P30CA091842Cancer Center Support Grant52025
T32DC009401University of Wisconsin Voice Research Training Program52025
U19AI070235Epithelial Genes in Allergic Inflammation52025
U19AI089674Program for Resistance, Immunology, Surveillance & Modeling of Malaria in Uganda (PRISM) Renewal52025
ZIAAI000483Malaria Drug Resistance and Disease Virulence52025
ZIAAI001066International Research in Cambodia: Tropical Medicine and Vector Research52025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/3860/grants